カテゴリ： 世界, 医療/バイオ, QYResearch

エキスポーチン1の世界市場2023年：染色体領域維持1蛋白質ホモログ、XPO1

■ 英語タイトル：Global Exportin 1 Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8755）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8755
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[エキスポーチン1の世界市場2023年：染色体領域維持1蛋白質ホモログ、XPO1]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はエキスポーチン1のグローバル市場について調査・分析し、世界のエキスポーチン1市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（染色体領域維持1蛋白質ホモログ、XPO1）、用途別セグメント分析（がん、中枢神経系、免疫、遺伝子疾患、感染症）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Biogen Inc、CanBas Co Ltd、Jiangsu Carephar Pharmaceutical Co Ltd、Karyopharm Therapeutics Inc、Oita University Institute of Advanced Medicine Inc、Wigen Biomedicine Technology (Shanghai) Co Ltdなどが含まれています。エキスポーチン1のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、エキスポーチン1市場規模を算出する際に考慮しました。

・エキスポーチン1市場の概要
- 製品の定義
- エキスポーチン1の種類別セグメント
- 世界のエキスポーチン1市場規模：タイプ別分析（染色体領域維持1蛋白質ホモログ、XPO1）
- エキスポーチン1の用途別セグメント
- 世界のエキスポーチン1市場規模：用途別分析（がん、中枢神経系、免疫、遺伝子疾患、感染症）
- 世界のエキスポーチン1市場規模予測（2018年-2029年）
- エキスポーチン1の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- エキスポーチン1市場の競争状況およびトレンド

・エキスポーチン1の地域別市場規模
- 北米のエキスポーチン1市場規模（2018年-2029年）
- 米国のエキスポーチン1市場規模（2018年-2029年）
- ヨーロッパのエキスポーチン1市場規模（2018年-2029年）
- アジア太平洋のエキスポーチン1市場規模（2018年-2029年）
- 中国のエキスポーチン1市場規模（2018年-2029年）
- 日本のエキスポーチン1市場規模（2018年-2029年）
- 韓国のエキスポーチン1市場規模（2018年-2029年）
- インドのエキスポーチン1市場規模（2018年-2029年）
- オーストラリアのエキスポーチン1市場規模（2018年-2029年）
- 中南米のエキスポーチン1市場規模（2018年-2029年）
- 中東・アフリカのエキスポーチン1市場規模（2018年-2029年）

・種類別セグメント：染色体領域維持1蛋白質ホモログ、XPO1
- 世界のエキスポーチン1のタイプ別販売量（2018年-2023年）
- 世界のエキスポーチン1のタイプ別売上（2018年-2023年）
- 世界のエキスポーチン1のタイプ別価格

・用途別セグメント：がん、中枢神経系、免疫、遺伝子疾患、感染症
- 世界のエキスポーチン1の用途別販売量（2018年-2023年）
- 世界のエキスポーチン1の用途別売上（2018年-2023年）
- 世界のエキスポーチン1の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Biogen Inc、CanBas Co Ltd、Jiangsu Carephar Pharmaceutical Co Ltd、Karyopharm Therapeutics Inc、Oita University Institute of Advanced Medicine Inc、Wigen Biomedicine Technology (Shanghai) Co Ltd

・産業チェーンと販売チャネルの分析
- エキスポーチン1産業チェーン分析
- エキスポーチン1の主要原材料
- エキスポーチン1の販売チャネル
- エキスポーチン1のディストリビューター
- エキスポーチン1の主要顧客

・エキスポーチン1市場ダイナミクス
- エキスポーチン1の業界動向
- エキスポーチン1市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) – Exportin 1 (XPO1) or chromosomal maintenance 1 (CRM1) is a eukaryotic protein. It mediates the nuclear export of cellular proteins bearing a leucine-rich nuclear export signal (NES) and of RNAs. In association with RANBP3, it binds cooperatively to the NES on its target protein and to the GTPase RAN in its active Ran-GTP. Docking of this complex to the nuclear pore complex (NPC) is mediated through binding to nucleoporins. It is involved in U3 snoRNA transport from Cajal bodies to nucleoli. The molecules developed by companies in Pre-Registration, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 1, 3, 1, 3 and 1 respectively.
Highlights
The global Exportin 1 market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Exportin 1 is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Exportin 1 is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Exportin 1 include Biogen Inc, CanBas Co Ltd, Jiangsu Carephar Pharmaceutical Co Ltd, Karyopharm Therapeutics Inc, Oita University Institute of Advanced Medicine Inc and Wigen Biomedicine Technology (Shanghai) Co Ltd, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Exportin 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exportin 1.
The Exportin 1 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Exportin 1 market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exportin 1 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Biogen Inc
CanBas Co Ltd
Jiangsu Carephar Pharmaceutical Co Ltd
Karyopharm Therapeutics Inc
Oita University Institute of Advanced Medicine Inc
Wigen Biomedicine Technology (Shanghai) Co Ltd
Segment by Type
Chromosome Region Maintenance 1 Protein Homolog
XPO1
Segment by Application
Oncology
Central Nervous System
Immunology
Genetic Disorders
Infectious Disease
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Exportin 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Exportin 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Exportin 1 Market Overview
1.1 Product Overview and Scope of Exportin 1
1.2 Exportin 1 Segment by Type
1.2.1 Global Exportin 1 Market Value Comparison by Type (2023-2029)
1.2.2 Chromosome Region Maintenance 1 Protein Homolog
1.2.3 XPO1
1.3 Exportin 1 Segment by Application
1.3.1 Global Exportin 1 Market Value by Application: (2023-2029)
1.3.2 Oncology
1.3.3 Central Nervous System
1.3.4 Immunology
1.3.5 Genetic Disorders
1.3.6 Infectious Disease
1.4 Global Exportin 1 Market Size Estimates and Forecasts
1.4.1 Global Exportin 1 Revenue 2018-2029
1.4.2 Global Exportin 1 Sales 2018-2029
1.4.3 Global Exportin 1 Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Exportin 1 Market Competition by Manufacturers
2.1 Global Exportin 1 Sales Market Share by Manufacturers (2018-2023)
2.2 Global Exportin 1 Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Exportin 1 Average Price by Manufacturers (2018-2023)
2.4 Global Exportin 1 Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Exportin 1, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Exportin 1, Product Type & Application
2.7 Exportin 1 Market Competitive Situation and Trends
2.7.1 Exportin 1 Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Exportin 1 Players Market Share by Revenue
2.7.3 Global Exportin 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Exportin 1 Retrospective Market Scenario by Region
3.1 Global Exportin 1 Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Exportin 1 Global Exportin 1 Sales by Region: 2018-2029
3.2.1 Global Exportin 1 Sales by Region: 2018-2023
3.2.2 Global Exportin 1 Sales by Region: 2024-2029
3.3 Global Exportin 1 Global Exportin 1 Revenue by Region: 2018-2029
3.3.1 Global Exportin 1 Revenue by Region: 2018-2023
3.3.2 Global Exportin 1 Revenue by Region: 2024-2029
3.4 North America Exportin 1 Market Facts & Figures by Country
3.4.1 North America Exportin 1 Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Exportin 1 Sales by Country (2018-2029)
3.4.3 North America Exportin 1 Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Exportin 1 Market Facts & Figures by Country
3.5.1 Europe Exportin 1 Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Exportin 1 Sales by Country (2018-2029)
3.5.3 Europe Exportin 1 Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Exportin 1 Market Facts & Figures by Country
3.6.1 Asia Pacific Exportin 1 Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Exportin 1 Sales by Country (2018-2029)
3.6.3 Asia Pacific Exportin 1 Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Exportin 1 Market Facts & Figures by Country
3.7.1 Latin America Exportin 1 Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Exportin 1 Sales by Country (2018-2029)
3.7.3 Latin America Exportin 1 Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Exportin 1 Market Facts & Figures by Country
3.8.1 Middle East and Africa Exportin 1 Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Exportin 1 Sales by Country (2018-2029)
3.8.3 Middle East and Africa Exportin 1 Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Exportin 1 Sales by Type (2018-2029)
4.1.1 Global Exportin 1 Sales by Type (2018-2023)
4.1.2 Global Exportin 1 Sales by Type (2024-2029)
4.1.3 Global Exportin 1 Sales Market Share by Type (2018-2029)
4.2 Global Exportin 1 Revenue by Type (2018-2029)
4.2.1 Global Exportin 1 Revenue by Type (2018-2023)
4.2.2 Global Exportin 1 Revenue by Type (2024-2029)
4.2.3 Global Exportin 1 Revenue Market Share by Type (2018-2029)
4.3 Global Exportin 1 Price by Type (2018-2029)
5 Segment by Application
5.1 Global Exportin 1 Sales by Application (2018-2029)
5.1.1 Global Exportin 1 Sales by Application (2018-2023)
5.1.2 Global Exportin 1 Sales by Application (2024-2029)
5.1.3 Global Exportin 1 Sales Market Share by Application (2018-2029)
5.2 Global Exportin 1 Revenue by Application (2018-2029)
5.2.1 Global Exportin 1 Revenue by Application (2018-2023)
5.2.2 Global Exportin 1 Revenue by Application (2024-2029)
5.2.3 Global Exportin 1 Revenue Market Share by Application (2018-2029)
5.3 Global Exportin 1 Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Biogen Inc
6.1.1 Biogen Inc Corporation Information
6.1.2 Biogen Inc Description and Business Overview
6.1.3 Biogen Inc Exportin 1 Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Biogen Inc Exportin 1 Product Portfolio
6.1.5 Biogen Inc Recent Developments/Updates
6.2 CanBas Co Ltd
6.2.1 CanBas Co Ltd Corporation Information
6.2.2 CanBas Co Ltd Description and Business Overview
6.2.3 CanBas Co Ltd Exportin 1 Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CanBas Co Ltd Exportin 1 Product Portfolio
6.2.5 CanBas Co Ltd Recent Developments/Updates
6.3 Jiangsu Carephar Pharmaceutical Co Ltd
6.3.1 Jiangsu Carephar Pharmaceutical Co Ltd Corporation Information
6.3.2 Jiangsu Carephar Pharmaceutical Co Ltd Description and Business Overview
6.3.3 Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Product Portfolio
6.3.5 Jiangsu Carephar Pharmaceutical Co Ltd Recent Developments/Updates
6.4 Karyopharm Therapeutics Inc
6.4.1 Karyopharm Therapeutics Inc Corporation Information
6.4.2 Karyopharm Therapeutics Inc Description and Business Overview
6.4.3 Karyopharm Therapeutics Inc Exportin 1 Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Karyopharm Therapeutics Inc Exportin 1 Product Portfolio
6.4.5 Karyopharm Therapeutics Inc Recent Developments/Updates
6.5 Oita University Institute of Advanced Medicine Inc
6.5.1 Oita University Institute of Advanced Medicine Inc Corporation Information
6.5.2 Oita University Institute of Advanced Medicine Inc Description and Business Overview
6.5.3 Oita University Institute of Advanced Medicine Inc Exportin 1 Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Oita University Institute of Advanced Medicine Inc Exportin 1 Product Portfolio
6.5.5 Oita University Institute of Advanced Medicine Inc Recent Developments/Updates
6.6 Wigen Biomedicine Technology (Shanghai) Co Ltd
6.6.1 Wigen Biomedicine Technology (Shanghai) Co Ltd Corporation Information
6.6.2 Wigen Biomedicine Technology (Shanghai) Co Ltd Description and Business Overview
6.6.3 Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Product Portfolio
6.6.5 Wigen Biomedicine Technology (Shanghai) Co Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Exportin 1 Industry Chain Analysis
7.2 Exportin 1 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Exportin 1 Production Mode & Process
7.4 Exportin 1 Sales and Marketing
7.4.1 Exportin 1 Sales Channels
7.4.2 Exportin 1 Distributors
7.5 Exportin 1 Customers
8 Exportin 1 Market Dynamics
8.1 Exportin 1 Industry Trends
8.2 Exportin 1 Market Drivers
8.3 Exportin 1 Market Challenges
8.4 Exportin 1 Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Exportin 1 Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Exportin 1 Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Exportin 1 Market Competitive Situation by Manufacturers in 2022
Table 4. Global Exportin 1 Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Exportin 1 Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Exportin 1 Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Exportin 1 Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Exportin 1 Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Exportin 1, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Exportin 1, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Exportin 1, Product Type & Application
Table 12. Global Key Manufacturers of Exportin 1, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Exportin 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exportin 1 as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Exportin 1 Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Exportin 1 Sales by Region (2018-2023) & (K Units)
Table 18. Global Exportin 1 Sales Market Share by Region (2018-2023)
Table 19. Global Exportin 1 Sales by Region (2024-2029) & (K Units)
Table 20. Global Exportin 1 Sales Market Share by Region (2024-2029)
Table 21. Global Exportin 1 Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Exportin 1 Revenue Market Share by Region (2018-2023)
Table 23. Global Exportin 1 Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Exportin 1 Revenue Market Share by Region (2024-2029)
Table 25. North America Exportin 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Exportin 1 Sales by Country (2018-2023) & (K Units)
Table 27. North America Exportin 1 Sales by Country (2024-2029) & (K Units)
Table 28. North America Exportin 1 Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Exportin 1 Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Exportin 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Exportin 1 Sales by Country (2018-2023) & (K Units)
Table 32. Europe Exportin 1 Sales by Country (2024-2029) & (K Units)
Table 33. Europe Exportin 1 Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Exportin 1 Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Exportin 1 Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Exportin 1 Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Exportin 1 Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Exportin 1 Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Exportin 1 Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Exportin 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Exportin 1 Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Exportin 1 Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Exportin 1 Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Exportin 1 Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Exportin 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Exportin 1 Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Exportin 1 Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Exportin 1 Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Exportin 1 Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Exportin 1 Sales (K Units) by Type (2018-2023)
Table 51. Global Exportin 1 Sales (K Units) by Type (2024-2029)
Table 52. Global Exportin 1 Sales Market Share by Type (2018-2023)
Table 53. Global Exportin 1 Sales Market Share by Type (2024-2029)
Table 54. Global Exportin 1 Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Exportin 1 Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Exportin 1 Revenue Market Share by Type (2018-2023)
Table 57. Global Exportin 1 Revenue Market Share by Type (2024-2029)
Table 58. Global Exportin 1 Price (US$/Unit) by Type (2018-2023)
Table 59. Global Exportin 1 Price (US$/Unit) by Type (2024-2029)
Table 60. Global Exportin 1 Sales (K Units) by Application (2018-2023)
Table 61. Global Exportin 1 Sales (K Units) by Application (2024-2029)
Table 62. Global Exportin 1 Sales Market Share by Application (2018-2023)
Table 63. Global Exportin 1 Sales Market Share by Application (2024-2029)
Table 64. Global Exportin 1 Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Exportin 1 Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Exportin 1 Revenue Market Share by Application (2018-2023)
Table 67. Global Exportin 1 Revenue Market Share by Application (2024-2029)
Table 68. Global Exportin 1 Price (US$/Unit) by Application (2018-2023)
Table 69. Global Exportin 1 Price (US$/Unit) by Application (2024-2029)
Table 70. Biogen Inc Corporation Information
Table 71. Biogen Inc Description and Business Overview
Table 72. Biogen Inc Exportin 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Biogen Inc Exportin 1 Product
Table 74. Biogen Inc Recent Developments/Updates
Table 75. CanBas Co Ltd Corporation Information
Table 76. CanBas Co Ltd Description and Business Overview
Table 77. CanBas Co Ltd Exportin 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. CanBas Co Ltd Exportin 1 Product
Table 79. CanBas Co Ltd Recent Developments/Updates
Table 80. Jiangsu Carephar Pharmaceutical Co Ltd Corporation Information
Table 81. Jiangsu Carephar Pharmaceutical Co Ltd Description and Business Overview
Table 82. Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Product
Table 84. Jiangsu Carephar Pharmaceutical Co Ltd Recent Developments/Updates
Table 85. Karyopharm Therapeutics Inc Corporation Information
Table 86. Karyopharm Therapeutics Inc Description and Business Overview
Table 87. Karyopharm Therapeutics Inc Exportin 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Karyopharm Therapeutics Inc Exportin 1 Product
Table 89. Karyopharm Therapeutics Inc Recent Developments/Updates
Table 90. Oita University Institute of Advanced Medicine Inc Corporation Information
Table 91. Oita University Institute of Advanced Medicine Inc Description and Business Overview
Table 92. Oita University Institute of Advanced Medicine Inc Exportin 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Oita University Institute of Advanced Medicine Inc Exportin 1 Product
Table 94. Oita University Institute of Advanced Medicine Inc Recent Developments/Updates
Table 95. Wigen Biomedicine Technology (Shanghai) Co Ltd Corporation Information
Table 96. Wigen Biomedicine Technology (Shanghai) Co Ltd Description and Business Overview
Table 97. Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Product
Table 99. Wigen Biomedicine Technology (Shanghai) Co Ltd Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Exportin 1 Distributors List
Table 103. Exportin 1 Customers List
Table 104. Exportin 1 Market Trends
Table 105. Exportin 1 Market Drivers
Table 106. Exportin 1 Market Challenges
Table 107. Exportin 1 Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Exportin 1
Figure 2. Global Exportin 1 Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Exportin 1 Market Share by Type in 2022 & 2029
Figure 4. Chromosome Region Maintenance 1 Protein Homolog Product Picture
Figure 5. XPO1 Product Picture
Figure 6. Global Exportin 1 Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Exportin 1 Market Share by Application in 2022 & 2029
Figure 8. Oncology
Figure 9. Central Nervous System
Figure 10. Immunology
Figure 11. Genetic Disorders
Figure 12. Infectious Disease
Figure 13. Global Exportin 1 Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Exportin 1 Market Size (2018-2029) & (US$ Million)
Figure 15. Global Exportin 1 Sales (2018-2029) & (K Units)
Figure 16. Global Exportin 1 Average Price (US$/Unit) & (2018-2029)
Figure 17. Exportin 1 Report Years Considered
Figure 18. Exportin 1 Sales Share by Manufacturers in 2022
Figure 19. Global Exportin 1 Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Exportin 1 Players: Market Share by Revenue in 2022
Figure 21. Exportin 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Exportin 1 Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Exportin 1 Sales Market Share by Country (2018-2029)
Figure 24. North America Exportin 1 Revenue Market Share by Country (2018-2029)
Figure 25. United States Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Exportin 1 Sales Market Share by Country (2018-2029)
Figure 28. Europe Exportin 1 Revenue Market Share by Country (2018-2029)
Figure 29. Germany Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Exportin 1 Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Exportin 1 Revenue Market Share by Region (2018-2029)
Figure 36. China Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Exportin 1 Sales Market Share by Country (2018-2029)
Figure 46. Latin America Exportin 1 Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Exportin 1 Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Exportin 1 Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Exportin 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Exportin 1 by Type (2018-2029)
Figure 56. Global Revenue Market Share of Exportin 1 by Type (2018-2029)
Figure 57. Global Exportin 1 Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Exportin 1 by Application (2018-2029)
Figure 59. Global Revenue Market Share of Exportin 1 by Application (2018-2029)
Figure 60. Global Exportin 1 Price (US$/Unit) by Application (2018-2029)
Figure 61. Exportin 1 Value Chain
Figure 62. Exportin 1 Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • EMR＆ESDナイフの世界市場インサイト・予測（～2028年）
  • 民生用リチウムイオン電池パックの世界市場2023年：100Wh以下、100-200Wh、201-400Wh、401-600Wh、600Wh以上
  • ペット用抗生剤の世界市場2023年：粉末、液体
  • ノイズキャンセリングスリープエイドヘッドフォンの世界市場2023年：ヘッドマウント、インイヤー、その他
  • α-1治療の世界市場2023年：増強療法、嚢胞性線維症（CF）、非CF気管支拡張症（NCFB）、糖尿病、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8755 )"エキスポーチン1の世界市場2023年：染色体領域維持1蛋白質ホモログ、XPO1" (英文：Global Exportin 1 Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。